Joseph N. Blattman

12.7k total citations · 4 hit papers
51 papers, 10.0k citations indexed

About

Joseph N. Blattman is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Joseph N. Blattman has authored 51 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 13 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Joseph N. Blattman's work include Immune Cell Function and Interaction (27 papers), Immunotherapy and Immune Responses (26 papers) and T-cell and B-cell Immunology (26 papers). Joseph N. Blattman is often cited by papers focused on Immune Cell Function and Interaction (27 papers), Immunotherapy and Immune Responses (26 papers) and T-cell and B-cell Immunology (26 papers). Joseph N. Blattman collaborates with scholars based in United States, France and Switzerland. Joseph N. Blattman's co-authors include Rafi Ahmed, E. John Wherry, Kaja Murali‐Krishna, Susan M. Kaech, Philip D. Greenberg, Daniel L. Barber, David Sourdive, John D. Altman, Sang‐Jun Ha and Robbert van der Most and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Joseph N. Blattman

50 papers receiving 9.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function

1998 1.6k citations Allan Zajac, Joseph N. Blattman et al. The Journal of Experimental Medicine profile →
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection

2007 1.5k citations E. John Wherry, Susan M. Kaech et al. profile →
Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment

2003 1.3k citations E. John Wherry, Joseph N. Blattman et al. Journal of Virology profile →
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection

2007 1.2k citations E. John Wherry, Susan M. Kaech et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph N. Blattman United States	32	7.8k	3.4k	1.7k	1.6k	859	51	10.0k
Awen Gallimore United Kingdom	51	6.1k 0.8×	2.3k 0.7×	1.4k 0.8×	1.2k 0.8×	1.1k 1.3×	122	8.1k
Emma Gostick United Kingdom	47	6.9k 0.9×	2.9k 0.9×	1.6k 1.0×	1.7k 1.1×	1.5k 1.8×	111	9.4k
Sang‐Jun Ha South Korea	45	6.3k 0.8×	3.8k 1.1×	2.1k 1.3×	1.3k 0.8×	541 0.6×	141	9.6k
W. Nicholas Haining United States	43	10.3k 1.3×	6.1k 1.8×	3.5k 2.1×	1.8k 1.1×	620 0.7×	78	14.5k
David G. Brooks United States	48	4.6k 0.6×	1.6k 0.5×	2.3k 1.3×	1.4k 0.9×	1.3k 1.5×	120	8.4k
Ross M. Kedl United States	46	7.4k 1.0×	1.8k 0.5×	1.8k 1.1×	1.1k 0.7×	333 0.4×	119	9.4k
P. Rod Dunbar New Zealand	56	9.0k 1.2×	2.4k 0.7×	2.9k 1.7×	2.1k 1.3×	1.7k 2.0×	159	12.8k
Michael A. Brehm United States	52	4.4k 0.6×	1.8k 0.5×	2.0k 1.2×	1.3k 0.8×	513 0.6×	161	8.4k
Kaja Murali‐Krishna United States	41	9.5k 1.2×	1.9k 0.6×	1.5k 0.9×	2.2k 1.4×	1.1k 1.2×	74	11.7k
François A. Lemonnier France	51	8.1k 1.0×	1.7k 0.5×	3.1k 1.8×	1.4k 0.9×	1.3k 1.5×	191	10.6k

Countries citing papers authored by Joseph N. Blattman

Since Specialization

Citations

This map shows the geographic impact of Joseph N. Blattman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph N. Blattman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph N. Blattman more than expected).

Fields of papers citing papers by Joseph N. Blattman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph N. Blattman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph N. Blattman. The network helps show where Joseph N. Blattman may publish in the future.

Co-authorship network of co-authors of Joseph N. Blattman

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph N. Blattman. A scholar is included among the top collaborators of Joseph N. Blattman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph N. Blattman. Joseph N. Blattman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hunter, Jesse M., et al.. (2025). Harnessing the microbiome to improve clinical outcomes for cancer, transplant, and immunocompromised patients in the intensive care unit (ICU). Frontiers in Cellular and Infection Microbiology. 15. 1577108–1577108. 1 indexed citations

Blattman, Joseph N., et al.. (2023). The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME). Frontiers in Cell and Developmental Biology. 11. 1141215–1141215. 10 indexed citations

Christie, John D., Nicole Appel, Liqiang Zhang, et al.. (2022). Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma. Cancers. 14(2). 337–337. 8 indexed citations

Marshall, Pamela A., et al.. (2022). Rexinoids Modulate Effector T Cell Expression of Mucosal Homing Markers CCR9 and α4β7 Integrin and Direct Their Migration In Vitro. Frontiers in Immunology. 13. 746484–746484. 4 indexed citations

Blattman, Joseph N., et al.. (2022). Flow Cytometry Analysis of Immune Cell Responses. Methods in molecular biology. 2597. 105–120. 2 indexed citations

Appel, Nicole, et al.. (2016). Progress and Opportunities for Immune Therapeutics in Osteosarcoma. Immunotherapy. 8(10). 1233–1244. 44 indexed citations

Holechek, Susan, et al.. (2016). Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination. Vaccine. 34(46). 5629–5635. 5 indexed citations

Lussier, Danielle M., et al.. (2016). Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet. BMC Cancer. 16(1). 310–310. 128 indexed citations

Lussier, Danielle M., Megan S. McAfee, Susan Holechek, et al.. (2015). Enhanced T-Cell Immunity to Osteosarcoma Through Antibody Blockade of PD-1/PD-L1 Interactions. Journal of Immunotherapy. 38(3). 96–106. 165 indexed citations

10.

Lussier, Danielle M., John L. Johnson, Pooja Hingorani, & Joseph N. Blattman. (2015). Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma. Journal for ImmunoTherapy of Cancer. 3(1). 21–21. 171 indexed citations

11.

Schietinger, Andrea, Jeffrey J. Delrow, Ryan Basom, Joseph N. Blattman, & Philip D. Greenberg. (2012). Rescued Tolerant CD8 T Cells Are Preprogrammed to Reestablish the Tolerant State. Science. 335(6069). 723–727. 126 indexed citations

12.

Tan, Xuefang, et al.. (2011). Retinoic Acid as a Vaccine Adjuvant Enhances CD8⁺T Cell Response and Mucosal Protection from Viral Challenge. Journal of Virology. 85(16). 8316–8327. 74 indexed citations

13.

Stromnes, Ingunn M., et al.. (2010). Abrogating Cbl-b in effector CD8+ T cells improves the efficacy of adoptive therapy of leukemia in mice. Journal of Clinical Investigation. 120(10). 3722–3734. 73 indexed citations

14.

Shin, Haina, Shawn D. Blackburn, Joseph N. Blattman, & E. John Wherry. (2007). Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. The Journal of Experimental Medicine. 204(4). 941–949. 208 indexed citations

15.

Wherry, E. John, Daniel L. Barber, Susan M. Kaech, Joseph N. Blattman, & Rafi Ahmed. (2004). Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proceedings of the National Academy of Sciences. 101(45). 16004–16009. 408 indexed citations

16.

Topp, Max S., Stanley R. Riddell, Yoshiki Akatsuka, et al.. (2003). Restoration of CD28 Expression in CD28− CD8 + Memory Effector T Cells Reconstitutes Antigen-induced IL-2 Production. The Journal of Experimental Medicine. 198(6). 947–955. 109 indexed citations

17.

Slifka, Mark K., Joseph N. Blattman, David Sourdive, et al.. (2003). Preferential Escape of Subdominant CD8+ T Cells During Negative Selection Results in an Altered Antiviral T Cell Hierarchy. The Journal of Immunology. 170(3). 1231–1239. 35 indexed citations

18.

Ho, William, Joseph N. Blattman, Michelle L. Dossett, Cassian Yee, & Philip D. Greenberg. (2003). Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction. Cancer Cell. 3(5). 431–437. 123 indexed citations

19.

Blattman, Joseph N., Rustom Antia, David Sourdive, et al.. (2002). Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells. The Journal of Experimental Medicine. 195(5). 657–664. 477 indexed citations

20.

Zajac, Allan, Joseph N. Blattman, Kaja Murali‐Krishna, et al.. (1998). Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function. The Journal of Experimental Medicine. 188(12). 2205–2213. 1602 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact